World Controlled Release Cardiovascular Therapeutics Market Analysis Report 2022: Evolving Drug Formulation Technology, Managed Care Initiatives, Growth in Self Administration, & Modified Release Technologies
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Controlled Release Cardiovascular Therapeutics" report has been added to ResearchAndMarkets.com's offering.
The prevalence and incidence of cardiovascular conditions in developed economies continue to increase, creating challenges and opportunities for cardiovascular drug developers.
While the vast majority of drugs for treating cardiovascular conditions are oral immediate release products, issues related to drug safety and patient compliance have focused attention on formulations that can improve drug safety profiles and reduce dosing frequency. Important treatment segments for controlled release cardiovascular drugs include angina, hypertension, arrhythmias, cholesterol, and peripheral artery disease.
Important growth factors for controlled release cardiovascular drugs include evolving patient demographics, environmental and lifestyle causative factors, increased public awareness of cardiovascular conditions and their associated morbidities, and expanded patient access to cardiovascular treatment services.
Controlled Release Cardiovascular Therapeutics - What You Will Learn
Analyzes and evaluates controlled release cardiovascular drug products and assesses the market potential for existing and probable future products
Analyzes product strategies, technologies and market development issues
Provides detailed analysis of cardiovascular market segments, market demographics, and therapeutic strategies
Profiles market sector companies, their product development activities, business strategies, and corporate alliances and affiliations
Evaluates the impact of economic, technology, and regulatory factors on cardiovascular drug markets
Key Topics Covered:
Executive Summary
Cardiovascular Therapeutics - Market Dynamics
The Cardiovascular Drug Landscape
Unmet Needs in Cardiovascular Clinical Treatment
Cardiovascular Drug Demand Drivers
Demographic Shifts
Evolving Drug Formulation Technology
Managed Care Initiatives
Growth in Self Administration
Modified Release Technologies
Oral
Advanced Film Coating Systems
Bead Systems
Bi-layer Tablets
Tri-layer Tablets
Microtablets
Transdermal
Cardiovascular Controlled Release Product Analysis
Cardiovascular Drug Commercialization Factors
Cardiovascular Segments for CR Therapeutics
Angina
Cholesterol Management
Heart Rhythm
Hypertension
Peripheral Artery Disease
Market Factors
Regulations and Approvals
US (FDA)
EU (EMEA)
Japan (PMDA)
Australia (TGA)
Managed Care and Healthcare Economics
Sector Participant Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/wubv5a
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900